Literature DB >> 2876632

Marked atypical lymphocytosis, hepatitis, and skin rash in sulfasalazine drug allergy.

G A Poland, K R Love.   

Abstract

A 38-year-old man presented with a generalized pruritic maculopapular rash, fever, myalgias, and edema of the face and neck. Laboratory examination revealed eosinophilia, atypical lymphocytosis, and abnormal liver function results. The clinical course was characterized by rapid resolution after initiation of steroid therapy and withdrawal of sulfasalazine, which had been started three weeks earlier for abdominal cramping and diarrhea. This clinical picture suggests a drug-induced hypersensitivity reaction to a drug commonly used for inflammatory bowel disease, sulfasalazine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876632     DOI: 10.1016/0002-9343(86)90562-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 2.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

3.  Drug hypersensitivity syndrome induced by sulfasalazine: A case report.

Authors:  Dong-Hui Chen; Hai-Rong Zhou; Yong-Gang Zhang; Guan-Yuan Shen; Chong Xu; Chun-Li Guan
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

4.  Case of relapsing sulfasalazine-induced hypersensitivity syndrome upon re-exposure.

Authors:  Jason Winward; Laurel Lyckholm; Samuel M Brown; Mohamad Mokadem
Journal:  BMJ Case Rep       Date:  2020-09-15

5.  Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.

Authors:  J L Huang; I J Hung; L C Chen; W Y Lee; C Hsueh; K H Hsieh
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.